Cite
HARVARD Citation
Takeuchi, T. et al. (2014). Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study. Annals of the rheumatic diseases. 73 (3), pp. 536-543. [Online].